Systemic evaluation of total Stat3 and Stat3 tyrosine phosphorylation in normal human tissues

Experimental and Molecular Pathology

Volumn 80, Issue 3, 2006, Pages 295-305

  Chen, Chun Liang ^a   Hsieh, Fu Chuan ^a   Lin, Jiayuh ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Human tissues; Stat3; Tissue microarray slides

Indexed keywords

PHOSPHOPROTEIN; STAT3 PROTEIN; TYROSINE;

ABSORPTION; ADULT; ARTICLE; CARDIOVASCULAR SYSTEM; CELL ACTIVITY; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; CELL TYPE; CIRCULATION; CONNECTIVE TISSUE; CONTROLLED STUDY; DIGESTIVE SYSTEM; ENDOTHELIUM CELL; EPITHELIUM CELL; EVALUATION; GENITAL SYSTEM; GOLGI COMPLEX; HEART; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; INTEGUMENT; LYMPHOID CELL; MUCOSA CELL; NERVOUS SYSTEM; NORMAL HUMAN; ORGAN; PERIPHERAL NERVE; PILOT STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RESPIRATORY SYSTEM; SECRETORY CELL; TISSUE; URINARY TRACT;

ADULT; HUMANS; IMMUNOHISTOCHEMISTRY; PHOSPHORYLATION; PILOT PROJECTS; PROTEIN ARRAY ANALYSIS; STAT3 TRANSCRIPTION FACTOR; TYROSINE;

EID: 33646536584     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2005.11.003     Document Type: Article

References (70)

1. Aggarwal S., Xie M.H., Maruoka M., Foster J., and Gurney A.L. Acinar cells of the pancreas are a target of interleukin-22. J. Interferon Cytokine Res. 21 (2001) 1047-1053
2. Antczak M., and Van Blerkom J. Oocyte influences on early development: the regulatory proteins leptin and STAT3 are polarized in mouse and human oocytes and differentially distributed within the cells of the preimplantation stage embryo. Mol. Hum. Reprod. 3 (1997) 1067-1086
3. Bowman T., Garcia R., Turkson J., and Jove R. STATs in oncogenesis. Oncogene 19 (2000) 2474-2488
4. Bromberg J.F., Horvath C.M., Besser D., Lathem W.W., and Darnell J.E.J. Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol. 18 (1998) 2553-2558
5. Bromberg J., Wrzeszczynska M., Devgan G., Zhao Y., Pestell R., Albanese C., and Darnell J.J. Stat3 as an oncogene. Cell 98 (1999) 295-303
6. Buettner R., Mora L., and Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin. Cancer Res. 8 (2002) 945-954
7. Chan K.S., Sano S., Kiguchi K., Anders J., Komazawa N., Takeda J., and DiGiovanni J. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J. Clin. Invest. 114 (2004) 720-728
8. Chapman R.S., Lourenco P.C., Tonner E., Flint D.J., Selbert S., Takeda K., Akira S., Clarke A.R., and Watson C.J. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev. 13 (1999) 2604-2616
9. Chen X., Vinkemeier U., Zhao Y., Jeruzalmi D., Darnell Jr. J.E., and Kuriyan J. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 93 (1998) 827-839
10. Chen X., Wang J., Zhou F., Wang X., and Feng Z. STAT proteins mediate angiotensin II-induced production of TIMP-1 in human proximal tubular epithelial cells. Kidney Int. 64 (2003) 459-467
11. Cheng J.G., Chen J.R., Hernandez L., Alvord W.G., and Stewart C.L. Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 8680-8685
12. Clevenger C.V. Roles and regulation of stat family transcription factors in human breast cancer. Am. J. Pathol. 165 (2004) 1449-1460
13. Darnell J.J., Kerr I., and Stark G. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264 (1994) 1415-1421
14. De Miguel M.P., De Boer-Brouwer M., Paniagua R., van den Hurk R., De Rooij D.G., and Van Dissel-Emiliani F.M. Leukemia inhibitory factor and ciliary neurotropic factor promote the survival of Sertoli cells and gonocytes in coculture system. Endocrinology 137 (1996) 1885-1893
15. Dolled-Filhart M., Camp R.L., Kowalski D.P., Smith B.L., and Rimm D.L. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis. Clin. Cancer Res. 9 (2003) 594-600
16. Duncan S.A., Zhong Z., Wen Z., and Darnell Jr. J.E. STAT signaling is active during early mammalian development. Dev. Dyn. 208 (1997) 190-198
17. Ernst M., and Jenkins B.J. Acquiring signalling specificity from the cytokine receptor gp130. Trends Genet. 20 (2004) 23-32
18. Gallmeier E., Schafer C., Moubarak P., Tietz A., Plossl I., Huss R., Goke B., and Wagner A.C. JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells. J. Cell. Physiol. 203 (2005) 209-216
19. Garcia R., and Jove R. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J. Biomed. Sci. 5 (1998) 79-85
20. Garcia R., Yu C., Hudnall A., Catlett R., Nelson K., Smithgall T., Fujita D., Ethier S., and Jove R. Constitutive activation of STAT 3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ. 8 (1997) 1267-1275
21. Gong W., Wang L., Yao J.C., Ajani J.A., Wei D., Aldape K.D., Xie K., Sawaya R., and Huang S. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Clin. Cancer Res. 11 (2005) 1386-1393
22. Guo G., Patel K., Kumar V., Shah M., Fried V., Etlinger J., and Sehgal P. Association of the chaperone glucose-regulated protein 58 (GRP58/ER-60/ERp57) with Stat3 in cytosol and plasma membrane complexes. J. Interferon Cytokine Res. 22 (2002) 555-563
23. Hilfiker-Kleiner D., Hilfiker A., Fuchs M., Kaminski K., Schaefer A., Schieffer B., Hillmer A., Schmiedl A., Ding Z., Podewski E., Poli V., Schneider M.D., Schulz R., Park J.K., Wollert K.C., and Drexler H. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ. Res. 95 (2004) 187-195
24. Hokuto I., Ikegami M., Yoshida M., Takeda K., Akira S., Perl A.K., Hull W.M., Wert S.E., and Whitsett J.A. Stat-3 is required for pulmonary homeostasis during hyperoxia. J. Clin. Invest. 113 (2004) 28-37
25. Humphreys R.C., Bierie B., Zhao L., Raz R., Levy D., and Hennighausen L. Deletion of Stat3 blocks mammary gland involution and extends functional competence of the secretory epithelium in the absence of lactogenic stimuli. Endocrinology 143 (2002) 3641-3650
26. Jacoby J.J., Kalinowski A., Liu M.G., Zhang S.S., Gao Q., Chai G.X., Ji L., Iwamoto Y., Li E., Schneider M., Russell K.S., and Fu X.Y. Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 12929-12934
27. Jenab S., and Morris P.L. Differential activation of signal transducer and activator of transcription (STAT)-3 and STAT-1 transcription factors and c-fos messenger ribonucleic acid by interleukin-6 and interferon-gamma in Sertoli cells. Endocrinology 137 (1996) 4738-4743
28. Jenab S., and Morris P.L. Testicular leukemia inhibitory factor (LIF) and LIF receptor mediate phosphorylation of signal transducers and activators of transcription (STAT)-3 and STAT-1 and induce c-fos transcription and activator protein-1 activation in rat Sertoli but not germ cells. Endocrinology 139 (1998) 1883-1890
29. Jenkins B.J., Quilici C., Roberts A.W., Grail D., Dunn A.R., and Ernst M. Hematopoietic abnormalities in mice deficient in gp130-mediated STAT signaling. Exp. Hematol. 30 (2002) 1248-1256
30. Kamimura D., Ishihara K., and Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev. Physiol. Biochem. Pharmacol. 149 (2003) 1-38
31. Kisseleva T., Bhattacharya S., Braunstein J., and Schindler C.W. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285 (2002) 1-24
32. Konnikova L., Kotecki M., Kruger M.M., and Cochran B.H. Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer 3 (2003) 23
33. Lee S.O., Lou W., Qureshi K.M., Mehraein-Ghomi F., Trump D.L., and Gao A.C. RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells. Prostate 60 (2004) 303-309
34. Leong P., Andrews G., Johnson D., Dyer K., Xi S., Mai J., Robbins P., Gadiparthi S., Burke N., Watkins S., and Grandis J. Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 4138-4143
35. Levy D.E., and Darnell Jr. J.E. Stats: transcriptional control and biological impact. Nat. Rev., Mol. Cell Biol. 3 (2002) 651-662
36. Levy D.E., and Lee C.K. What does Stat3 do?. J. Clin. Invest. 109 (2002) 1143-1148
37. Ling X., and Arlinghaus R.B. Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice. Cancer Res. 65 (2005) 2532-2536
38. Minami M., Inoue M., Wei S., Takeda K., Matsumoto M., Kishimoto T., and Akira S. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 3963-3966
39. Miyoshi K., Cui Y., Riedlinger G., Robinson P., Lehoczky J., Zon L., Oka T., Dewar K., and Hennighausen L. Structure of the mouse Stat 3/5 locus: evolution from Drosophila to zebrafish to mouse. Genomics 71 (2001) 150-155
40. Murphy K., Carvajal L., Medico L., and Pepling M. Expression of Stat3 in germ cells of developing and adult mouse ovaries and testes. Gene Expression Patterns 5 (2005) 475-482
41. Nagalakshmi M.L., Rascle A., Zurawski S., Menon S., and de Waal Malefyt R. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int. Immunopharmacol. 4 (2004) 679-691
42. Ndubuisi M.I., Guo G.G., Fried V.A., Etlinger J.D., and Sehgal P.B. Cellular physiology of STAT3: where's the cytoplasmic monomer?. J. Biol. Chem. 274 (1999) 25499-25509
43. Niu G., Heller R., Catlett-Falcone R., Coppola D., Jaroszeski M., Dalton W., Jove R., and Yu H. Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res. 59 (1999) 5059-5063
44. Pedranzini L., Leitch A., and Bromberg J. Stat3 is required for the development of skin cancer. J. Clin. Invest. 114 (2004) 619-622
45. Philp J.A., Burdon T.G., and Watson C.J. Differential activation of STATs 3 and 5 during mammary gland development. FEBS Lett. 396 (1996) 77-80
46. Planas A.M., Berruezo M., Justicia C., Barron S., and Ferrer I. Stat3 is present in the developing and adult rat cerebellum and participates in the formation of transcription complexes binding DNA at the sis-inducible element. J. Neurochem. 68 (1997) 1345-1351
47. Proietti C., Salatino M., Rosemblit C., Carnevale R., Pecci A., Kornblihtt A.R., Molinolo A.A., Frahm I., Charreau E.H., Schillaci R., and Elizalde P.V. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. Mol. Cell. Biol. 25 (2005) 4826-4840
48. Rajan P., Symes A.J., and Fink J.S. STAT proteins are activated by ciliary neurotrophic factor in cells of central nervous system origin. J. Neurosci. Res. 43 (1996) 403-411
49. Real P., Sierra A., De Juan A., Segovia J., Lopez-Vega J., and Fernandez-Luna J. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Oncogene 21 (2002) 7611-7618
50. Sano S., Itami S., Takeda K., Tarutani M., Yamaguchi Y., Miura H., Yoshikawa K., Akira S., and Takeda J. Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J. 18 (1999) 4657-4668
51. Sano S., Takahama Y., Sugawara T., Kosaka H., Itami S., Yoshikawa K., Miyazaki J., van Ewijk W., and Takeda J. Stat3 in thymic epithelial cells is essential for postnatal maintenance of thymic architecture and thymocyte survival. Immunity 15 (2001) 261-273
52. Schaefer T., Sanders L., and Nathans D. Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 9097-9101
53. Schindler C., and Darnell Jr. J.E. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64 (1995) 621-651
54. Schweizer U., Gunnersen J., Karch C., Wiese S., Holtmann B., Takeda K., Akira S., and Sendtner M. Conditional gene ablation of Stat3 reveals differential signaling requirements for survival of motoneurons during development and after nerve injury in the adult. J. Cell Biol. 156 (2002) 287-298
55. Selander K.S., Li L., Watson L., Merrell M., Dahmen H., Heinrich P.C., Muller-Newen G., and Harris K.W. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy. Cancer Res. 64 (2004) 6924-6933
56. Shen Y., Schlessinger K., Zhu X., Meffre E., Quimby F., Levy D.E., and Darnell Jr. J.E. Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation. Mol. Cell. Biol. 24 (2004) 407-419
57. Song H., Wang R., Wang S., and Lin J. A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 4700-4705
58. Stephens J.M., Morrison R.F., and Pilch P.F. The expression and regulation of STATs during 3T3-L1 adipocyte differentiation. J. Biol. Chem. 271 (1996) 10441-10444
59. Takamiya A., Takeda M., Yoshida A., and Kiyama H. Inflammation induces serine protease inhibitor 3 expression in the rat pineal gland. Neuroscience (2002) 387-394
60. Takeda K., and Akira S. STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev. 11 (2000) 199-207
61. Takeda K., and Akira S. Multi-functional roles of Stat3 revealed by conditional gene targeting. Arch. Immunol. Ther. (2001) 279-283
62. Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., Kishimoto T., and Akira S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 3801-3804
63. Takeda K., Kaisho T., Yoshida N., Takeda J., Kishimoto T., and Akira S. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161 (1998) 4652-4660
64. Takeda K., Clausen B.E., Kaisho T., Tsujimura T., Terada N., Forster I., and Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10 (1999) 39-49
65. Vona-Davis L.C., Frankenberry K.A., Waheed U., Peterson E., and McFadden D.W. Expression of STAT3 and SOCS3 in pancreatic acinar cells. J. Surg. Res. 127 (2005) 14-20
66. Wen Z., and Darnell Jr. J.E. Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res. 25 (1997) 2062-2067
67. Yang J., Chatterjee-Kishore M., Staugaitis S.M., Nguyen H., Schlessinger K., Levy D.E., and Stark G.R. Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation. Cancer Res. 65 (2005) 939-947
68. Yu C.R., Young H.A., and Ortaldo J.R. Characterization of cytokine differential induction of STAT complexes in primary human T and NK cells. J. Leukocyte Biol. 64 (1998) 245-258
69. Zhao L., Hart S., Cheng J., Melenhorst J.J., Bierie B., Ernst M., Stewart C., Schaper F., Heinrich P.C., Ullrich A., Robinson G.W., and Hennighausen L. Mammary gland remodeling depends on gp130 signaling through Stat3 and MAPK. J. Biol. Chem. 279 (2004) 44093-44100
70. Zhong Z., Wen Z., and Darnell Jr. J.E. Stat3 and Stat4: members of the family of signal transducers and activators of transcription. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 4806-4810